Document Detail


Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion.
MedLine Citation:
PMID:  19261918     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Partial exchange transfusion with a cell-free hemoglobin (Hb) polymer during transient middle cerebral artery occlusion (MCAO) reduces infarct volume but fails to increase blood flow, as might be expected with the induced decrease in hematocrit. In ischemic brain, endothelin antagonists are known to produce vasodilation. In nonischemic brain, pial arterioles constrict after Hb exchange transfusion, and the constriction is blocked by an inhibitor of 20-HETE synthesis. We tested the hypothesis that a 20-HETE synthesis inhibitor and an endothelin A receptor antagonist increase pial arteriolar dilation after Hb exchange transfusion during MCAO. Pial arteriolar diameter was measured in the ischemic border region of the distal MCA border region through closed cranial windows in anesthetized rats subjected to the filament model of MCAO. During 2 h of MCAO, pial arteriolar dilation gradually subsided from 37 +/- 3 to 7 +/- 5% (+/-SE). Compared with residual dilation at 2 h of MCAO with vehicle superfusion (14 +/- 3%), loss of dilation was not prevented by superfusion of a 20-HETE synthesis inhibitor (21 +/- 5%), partial Hb exchange transfusion (7 +/- 5%) that decreased hematocrit to 23%, or a combination of the two (5 +/- 5%). However, loss of dilation was prevented by superfusion of an endothelin A receptor antagonist with (35 +/- 4%) or without (32 +/- 5%) Hb transfusion. Pial artery constriction during reperfusion was attenuated by HET0016 alone and by BQ610 with or without Hb transfusion. Systemic administration of the endothelin antagonist during prolonged MCAO increased blood flow in the border region. Thus loss of pial arteriolar dilation in the ischemic border region during prolonged MCAO depends on endothelin A receptor activation, and this effect was independent of the presence of cell-free Hb polymers in the plasma. In contrast to previous work in nonischemic brain, inhibition of oxygen-dependent 20-HETE synthesis does not significantly influence the pial arteriolar response to polymeric Hb exchange transfusion during focal ischemia.
Authors:
Suyi Cao; Liang-Chao Wang; Herman Kwansa; Richard J Roman; David R Harder; Raymond C Koehler
Related Documents :
15225928 - Effects of operating conditions on the removal of heavy metals by zeolite in fixed bed ...
9279908 - Chlorine and sodium perfusion and electrolyte balance in human tissue and tumours befor...
12477188 - Determination of ciprofloxacin with a room-temperature phosphorescence flow-through sen...
7965498 - Gas exchange across native lungs and extracorporeal membrane in neonates and pigs durin...
4039548 - Nasal blood flow and airway resistance. canine study.
22566388 - Indications and complications of transfusions in sickle cell disease.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2009-03-04
Journal Detail:
Title:  American journal of physiology. Regulatory, integrative and comparative physiology     Volume:  296     ISSN:  0363-6119     ISO Abbreviation:  Am. J. Physiol. Regul. Integr. Comp. Physiol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-28     Completed Date:  2009-06-25     Revised Date:  2011-01-27    
Medline Journal Info:
Nlm Unique ID:  100901230     Medline TA:  Am J Physiol Regul Integr Comp Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  R1412-8     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amidines / pharmacology
Animals
Arterioles / drug effects,  physiology*
Blood Substitutes / administration & dosage,  pharmacology
Blood Transfusion
Brain Ischemia / physiopathology*
Endothelins / antagonists & inhibitors,  physiology*
Hemoglobins / administration & dosage,  pharmacology*
Hydroxyeicosatetraenoic Acids / antagonists & inhibitors,  physiology*
Male
Models, Animal
Oligopeptides / pharmacology
Pia Mater / blood supply*
Polymers
Rats
Rats, Wistar
Receptor, Endothelin A / antagonists & inhibitors
Regional Blood Flow / drug effects,  physiology
Vasodilation / drug effects,  physiology*
Grant Support
ID/Acronym/Agency:
HL59996/HL/NHLBI NIH HHS; NS38684/NS/NINDS NIH HHS; R01 HL033833-26/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Amidines; 0/Blood Substitutes; 0/Endothelins; 0/Hemoglobins; 0/Hydroxyeicosatetraenoic Acids; 0/N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine; 0/Oligopeptides; 0/Polymers; 0/Receptor, Endothelin A; 141595-53-1/BQ 610; 79551-86-3/20-hydroxy-5,8,11,14-eicosatetraenoic acid
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of physiological levels of caffeine on Ca2+ handling and fatigue development in Xenopus isola...
Next Document:  Pentamidine Movement across the Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers: Effect of...